64 related articles for article (PubMed ID: 2949801)
1. [Early induction of diabetes in NOD mice by streptozotocin].
Orlow S; Yasunami R; Boitard C; Bach JF
C R Acad Sci III; 1987; 304(3):77-8. PubMed ID: 2949801
[TBL] [Abstract][Full Text] [Related]
2. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
3. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
[TBL] [Abstract][Full Text] [Related]
4. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
5. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
6. Genetic control of low-dose streptozotocin-induced autoimmune diabetes in mice.
Kiesel U; Falkenberg FW; Kolb H
J Immunol; 1983 Apr; 130(4):1719-22. PubMed ID: 6833751
[TBL] [Abstract][Full Text] [Related]
7. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
Kimura T; Ito A; Hancock WW; Maki T
J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
Zunino SJ; Simons LF; Sambrook JF; Gething MJ
Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to streptozotocin-induced diabetes is mapped to mouse chromosome 11.
Babaya N; Ikegami H; Fujisawa T; Nojima K; Itoi-Babaya M; Inoue K; Ohno T; Shibata M; Ogihara T
Biochem Biophys Res Commun; 2005 Mar; 328(1):158-64. PubMed ID: 15670764
[TBL] [Abstract][Full Text] [Related]
10. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
Atlan-Gepner C; Hermitte L; Janand-Delenne B; Naquet P; Vialettes B
Diabetes Metab; 1997 Nov; 23(5):386-94. PubMed ID: 9416430
[TBL] [Abstract][Full Text] [Related]
11. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes.
Gonzalez C; Cuvellier S; Hue-Beauvais C; Lévi-Strauss M
Diabetologia; 2003 Sep; 46(9):1291-5. PubMed ID: 12879252
[TBL] [Abstract][Full Text] [Related]
13. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
14. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
[TBL] [Abstract][Full Text] [Related]
15. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
Peterson JD; Pike B; McDuffie M; Haskins K
J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
17. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
18. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
19. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
20. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
Herold KC; Baumann E; Vezys V; Buckingham F
J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
